Company Profile
Ibio Inc Stock Price, News & Analysis
- Ticker:
- IBIO
- Exchange:
- 美国证券交易所
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on 美国证券交易所, IBIO is followed within the biotech universe for its exposure to catalyst-driven execution.
Stock performance
1.65 USD (-5.17%)
Close
Last updated: June 23, 2026 at 00:00
81.97M USD
Market cap
Why the stock is moving
IBIO is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
IBIO is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on 美国证券交易所, IBIO is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
IBIO follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, IBIO sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
iBio to Participate in Upcoming Healthcare Investor Conferences
Source: Ibio Inc
- 02
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Ibio Inc (IBIO)?
Ibio Inc (IBIO) most recently closed at 1.65 USD, a -5.17% move versus the previous session.
What is the market cap of Ibio Inc (IBIO)?
Ibio Inc currently has a market capitalization of 81.97M USD on BioPharmSignal.
What does Ibio Inc do?
IBIO is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
On which exchange is IBIO stock listed?
Ibio Inc (IBIO) is associated with 美国证券交易所, Headquartered in the United States and listed on 美国证券交易所, IBIO is followed within the biotech universe for its exposure to catalyst-driven execution., Biotechnology.
What is Investors?
Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Which conditions is Ibio Inc targeting with Investors?
IBIO is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.